Researchers at the School of Pharmacy will be participating in local medical research arising from three new starter grants provided by the Royal Hobart Hospital Research Foundation.
The Research Foundation’s Chair, Mr David Catchpole, explained “the purpose of these grants is to assist emerging and highly skilled clinical researchers to collaborate with each other for the benefit of the local community”.
The projects being undertaken see researchers from the School collaborating with other schools in the University and clinicians at the Royal Hobart Hospital.
Associate Professor Nuri Güven and Dr Rosanne Guijt of the School of Pharmacy are both co-investigators alongside Dr Jason Smith of the School of Chemistry, working on the project ‘Neuroprotective function of novel short chain quinones’, led by Associate Professor Paul McCartney of the Royal Hobart Hospital.
Professor Greg Peterson, Dr Luke Bereznicki, Mr Angus Thompson and Ms Felicity Veal of the School of Pharmacy are co-investigators of the project ‘Management of post-operative pain and the progression to persistent post-operative pain’, led by Dr Chris Orlikowski of the Royal Hobart Hospital.
Dr Rahul Patel of the School of Pharmacy is co-investigator of the project ‘The physical and chemical stability of amoxicillin, daptomycin and quinupristin/dalfopristin in Dianeal, Extraneal or Fresenius peritoneal dialysis solution under three different storage conditions’ led by Mr Troy Wanandy of the Royal Hobart Hospital.
Successful applications were selected based on their scope and the intended benefits to the community.
Each project has received a $10,000 starter grant.